LMR Partners’s Pyxis Oncology PYXS Stock Holding History
Bought
Maintained
Sold
Other funds holding PYXS
LMR Partners's PYXS Position: Q3 2026 in Review
LMR Partners opened a new position in Pyxis Oncology (PYXS) in Q3 2026: 482,750 shares worth $1.12M. The stake represents ﹤0.01% of the portfolio and ranks #1058 among its holdings. This is a return to the name: LMR Partners previously reported a position in PYXS as recently as Q4 2024.
LMR Partners first reported a position in PYXS in Q3 2024 and has held it in 3 quarters since. 101 funds tracked by Wall St. Rank hold PYXS as of Q3 2026.
- LMR Partners held 482,750 shares of Pyxis Oncology worth $1.12M as of Q3 2026.
- Pyxis Oncology was a new LMR Partners position in Q3 2026.
- Pyxis Oncology made up ﹤0.01% of LMR Partners's portfolio in Q3 2026, its #1058 holding.
- LMR Partners first reported a position in Pyxis Oncology in Q3 2024 and has held it in 3 quarters since.
- 101 funds tracked by Wall St. Rank held Pyxis Oncology as of Q3 2026.
Based on LMR Partners's 13F filing for Q3 2026, filed 16 Nov 2026.